Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients (Q41715953)

7 October 2017

Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients (English)

1 reference

7 October 2017

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Dalila L Zanette

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Belinda Pinto Simoes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Rodrigo A Panepucci

1 reference

ORCID Public Data File 2021

author name string

L C M Arruda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

J C C Lorenzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

A P A Sousa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

P V B Palma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

R A Panepucci

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

D S Brum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

A A Barreira

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

W A Silva

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

M C Oliveira

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

K C R Malmegrim

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

8 December 2014

1 reference

Bone Marrow Transplantation

7 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

380-389

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2014.277

11 June 2020

exact match

0 references

cites work

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

T cell repertoire following autologous stem cell transplantation for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Decreased FOXP3 levels in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

microRNAs and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

MicroRNAs: new regulators of immune cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

MicroRNA control in the immune system: basic principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Genetic association and altered gene expression of mir-155 in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

miRNA profiling of naïve, effector and memory CD8 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Treatment of severe autoimmune disease by stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.277

PD-1 deletion restores susceptibility to experimental autoimmune encephalomyelitis in miR-155-deficient mice

21 January 2018

1 reference

12 December 2020

Renewing the T cell repertoire to arrest autoimmune aggression

1 reference

12 December 2020

MicroRNA dysregulation in multiple sclerosis

1 reference

12 December 2020

CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity

1 reference

12 December 2020

Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network

1 reference

12 December 2020

A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2014.277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

11 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25486582%20AND%20SRC:MED&resulttype=core&format=json